United States · FDA National Drug Code directory
Glipizide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82804-959_f5d7a98c-d1d4-43b9-8d7e-830a33ae0c24
- Product NDC
- 82804-959
- Form
- TABLET
- Composition / generic term
- Glipizide
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250501
- Source listing expiry
- 20271231
Source-listed ingredients
- GLIPIZIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (82804-959-00) · 82804-959-00
- 1000 TABLET in 1 BOTTLE (82804-959-11) · 82804-959-11
- 30 TABLET in 1 BOTTLE (82804-959-30) · 82804-959-30
- 500 TABLET in 1 BOTTLE (82804-959-55) · 82804-959-55
- 60 TABLET in 1 BOTTLE (82804-959-60) · 82804-959-60
- 120 TABLET in 1 BOTTLE (82804-959-72) · 82804-959-72
- 90 TABLET in 1 BOTTLE (82804-959-90) · 82804-959-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →